Form 8-K - Current report:
SEC Accession No. 0001683168-24-004119
Filing Date
2024-06-11
Accepted
2024-06-11 15:12:03
Documents
15
Period of Report
2024-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cardiff_8k.htm   iXBRL 8-K 30434
2 SETTLEMENT AGREEMENT AND RELEASE OF CLAIMS, DATED JUNE 11, 2024, BETWEEN CARDIFF cardiff_ex1001.htm EX-10.1 52106
3 FIXED AMOUNT SETTLEMENT PROMISSORY NOTE ISSUED BY CARDIFF LEXINGTON CORPORATION cardiff_ex1002.htm EX-10.2 46290
  Complete submission text file 0001683168-24-004119.txt   320212

Data Files

Seq Description Document Type Size
4 XBRL PRESENTATION FILE cdif-20240611_pre.xml EX-101.PRE 22375
5 XBRL LABEL FILE cdif-20240611_lab.xml EX-101.LAB 34240
6 XBRL SCHEMA FILE cdif-20240611.xsd EX-101.SCH 3039
18 EXTRACTED XBRL INSTANCE DOCUMENT cardiff_8k_htm.xml XML 3262
Mailing Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169
Business Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169 844-628-2100
Cardiff Lexington Corp (Filer) CIK: 0000811222 (see all company filings)

EIN.: 841044583 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-49709 | Film No.: 241035513
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 03 Life Sciences)